Overview of Cenforce Soft 100mg Pharmaceutical
Cenforce Soft 100mg is a pharmaceutical preparation containing sildenafil citrate, formulated as a sublingual tablet for laboratory research purposes. This phosphodiesterase type 5 (PDE5) inhibitor represents a standardised pharmaceutical formulation enabling researchers to examine the biochemical mechanisms underlying nitric oxide signalling pathways in controlled laboratory environments. The soft formulation allows for rapid dissolution studies and bioavailability research applications. Scientists at Stroid UK Shop utilise these pharmaceutical preparations to investigate vascular physiology and cellular signalling mechanisms in experimental models.
Laboratory Research Applications
Research applications for Cenforce Soft 100mg encompass vascular biology studies, examining how PDE5 inhibition affects cyclic GMP metabolism in cellular systems. Laboratory investigations focus on endothelial function research, studying nitric oxide pathways and smooth muscle relaxation mechanisms in tissue culture models. Researchers in the Cenforce category examine dissolution kinetics of sublingual formulations compared to traditional tablet forms. Comparative studies with other research compounds from our SARMs collection and peptides section provide insights into different molecular mechanisms affecting cellular function and signalling pathways.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Sildenafil Citrate |
| Strength | 100mg per tablet |
| Formulation | Sublingual soft tablet |
| CAS Number | 139755-83-2 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.70 g/mol |
| Storage | Room temperature, dry conditions |
| Shelf Life | As per manufacturer guidelines |
Research Use Compliance
Cenforce Soft 100mg is supplied exclusively for legitimate scientific research purposes in certified laboratory facilities. This pharmaceutical preparation is not intended for human consumption, clinical application, or therapeutic use. Researchers must maintain appropriate safety protocols when handling pharmaceutical compounds and ensure compliance with institutional research guidelines. All studies should be conducted under appropriate ethical oversight and regulatory approval where required for pharmaceutical research activities.
